PRAXIS PRECISION MEDICINES, INC. Marketable Securities (Current)
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Marketable Securities (Current) of $283.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-06
- 2026-06-30: Marketable Securities, Current $283.79M.
- 2026-03-31: Marketable Securities, Current $250.53M.
- 2025-12-31: Marketable Securities, Current $242.00M.
- 2024-12-31: Marketable Securities, Current $177.19M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $283.79M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $250.53M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $242.00M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $177.19M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |